Codes ATC:
A10AC01
Indication
Type 2 diabetes mellitus
Code ICD11:
5A11
INN
Isophane insulin
Type de médicament
Biological agent
Type de liste
Liste de base
Additional notes
including quality-assured biosimilars
Formulations
Parenteral > General injections > SC:
40 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin ;
100 IU per mL in 10 mL vial as compound insulin zinc suspension or isophane insulin ;
100 IU per mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin ;
100 IU per mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin
Historique des statuts LME
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the medicine description be updated to replace 'Intermediate-acting insulin' with 'Insulin (human, intermediate-acting).